Comparison of Transradial vs. Transfemoral Approach in the Treatment of Acute Myocardial Infarction with Primary Angioplasty and Abciximab

Catheterization and Cardiovascular Interventions

Volumn 61, Issue 1, 2004, Pages 67-73

  Philippe, Francois ^a   Larrazet, Fabrice ^a   Meziane, Tarek ^a   Dibie, Alain ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Abciximab; Complications; Coronary angioplasty; Transradial access

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD TRANSFUSION; BLOOD VESSEL CATHETERIZATION; CANNULATION; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE HEMORRHAGE; RADIAL ARTERY; RADIATION DOSE; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULAR ACCESS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; FEMALE; FEMORAL ARTERY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE COMPLICATIONS; RADIAL ARTERY; TREATMENT OUTCOME;

EID: 0346732106     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10675     Document Type: Article

References (24)

1. EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
2. Aguirre FV, Topol EJ, Ferguson J, et al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 1995;91:2890-2892.
3. Ferguson JJ, Kereiakes DJ, Adgey AAJ, et al. Safe use of platelet GP IIb/IIIa inhibitors. Eur Heart J 1998;19(Suppl D):31-39.
4. Lotan C, Hasin Y, Mosseri M, et al. Trans-radial approach for coronary angiography and angioplasty. Am J Cardiol 1995;76:164-167.
5. Barbeau G, Carrier G, Ferland S, Letourneau L, Gleeton O, Larivière M. Right trans-radial approach for coronary procedures: preliminary results. J Invas Cardiol 1996;8:19D-21D.
6. Kiemeneij F, Laarman GJ. Trans-radial artery Palmaz-Schatz coronary stent implantation: results of a single-center feasibility study. Am Heart J 1995;130:14-21.
7. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wicken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-1275.
8. Mann T, Cubeddu G, and Bowen J, et al. Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol 1998;32:572-576.
9. EPILOG investigators. Effects of platelet glycoprotein IIb/IIIa receptor inhibitor abciximab with lower heparin dosages on ischemic complications of percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
10. CAPTURE investigators. Randomised placebo controlled trial of abciximab before and during intervention in refractory unstable angina: the CAPTURE study. Lancet 1997;349:1429-1435.
11. EPISTENT investigators. Randomised placebo controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87-92.
12. Chronos N, Vahanian A, Betriu A, et al. Use of abciximab in interventional cardiology. Eur Heart J 1998;19(Suppl D):31-39.
13. Louvard Y, Ludwig J, Lefevre T, et al. Transradial approach for coronary angioplasty in the setting of acute myocardial infarction: a dual-center registry. Cathet Cardiovasc Intervent 2002;55:206-211
14. Hamon M, Sabatier R, Zhao Q, Niculescu R, Valette B, Grollier G. Mini-invasive strategy in acute coronary syndromes: direct coronary stenting using 5 Fr guiding catheters and transradial approach. Cathet Cardiovasc Intervent 2002;55:340-343.
15. Choussat R, Black A, Bossi I, Fajadet J, Marco J. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade: comparison of transradial vs. transfemoral arterial access. Eur Heart J 2000;21:662-667.
16. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction: ADMIRAL investigators. N Engl J Med 2001;344:1895-1903.
17. Arnold A. Hemostasis after radial artery cardiac catheterization. J Invas Cardiol 1996;8(Suppl D):26-29.
18. Bhatt DL, Bertrand ME, Berger PB, et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002;39:9-14.
19. Kiemeneij F, Laarman GJ. Percutaneous trans-radial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn 1993;30:173-178.
20. Benit E, Missault L, Berman T, et al. Brachial, radial or femoral approach for elective Palmaz-Schatz implantation: a randomized comparison. Cathet Cardiovasc Diagn 1997;41:124-130.
21. Louvard Y, Lefevre T, Morice M-C. Radial approach: what about the learning curve? Cathet Cardiovasc Diagn 1997;41:124-130.
22. Louvard Y, Lefevre T, Allain A, Morice M. Coronary angiography through the radial or the femoral approach: the CARAFE study. Cathet Cardiovasc Intervent 2001;52:181-187.
23. Nagai S, Abe S, Sato T, Hozawa K, Yuki K, Hanashima K, Tamoike H. Ultrasonic assessment of vascular complications in coronary angiography and angioplasty after transradial approach. Am J Cardiol 1999;83:180-186.
24. Stella PR, Kiemeneij F, Laarman GH, et al. Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn 1997;40:156-158.